Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

47 results about "Low molecular weight protein" patented technology

The ras protein belongs to a large super-family of proteins known as "low-molecular weight G-proteins". These proteins are called "G-proteins" because they bind guanine nucleotides (GTP and GDP).

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

The present invention relates to methods and compositions designed for treatment, management, or prevention of a hyperproliferative cell disease, particular cancer. The methods of the invention comprise the administration of an effective amount of a composition that targets cells expressing low molecular weight protein tyrosine kinase (“LMW-PTP”) in particular using moieties that bind an Eph family receptor tyrosine kinase, such as EphA2 or EphA4, and inhibits or reduces LMW-PTP expression and / or activity. In one embodiment, the method of the invention comprises administering to a subject a composition comprising an EphA2 or EphA4 targeting moiety attached to a delivery vehicle, and one or more agents that inhibit LMW-PTP expression and / or activity operatively associated with the delivery vehicle. In another embodiment, the method of the invention comprises administering to a subject a composition comprising a nucleic acid comprising a nucleotide sequence encoding an EphA2 or EphA4 targeting moiety and an agent that inhibits or reduces LMW-PTP expression and / or activity. In yet another embodiment, the method of the invention comprises administering to a subject a composition comprising an EphA2 or EphA4 targeting moiety and a nucleic acid comprising a nucleotide sequence encoding an agent that inhibits or reduces LMW-PTP expression and / or activity, where the nucleic acid is operatively associated with the delivery vehicle. Pharmaceutical compositions are also provided by the present invention.
Owner:MEDIMMUNE LLC

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

The present invention relates to methods and compositions designed for treatment, management, or prevention of a hyperproliferative cell disease, particular cancer. The methods of the invention comprise the administration of an effective amount of a composition that targets cells expressing low molecular weight protein tyrosine kinase (“LMW-PTP”) in particular using moieties that bind an Eph family receptor tyrosine kinase, such as EphA2 or EphA4, and inhibits or reduces LMW-PTP expression and / or activity. In one embodiment, the method of the invention comprises administering to a subject a composition comprising an EphA2 or EphA4 targeting moiety attached to a delivery vehicle, and one or more agents that inhibit LMW-PTP expression and / or activity operatively associated with the delivery vehicle. In another embodiment, the method of the invention comprises administering to a subject a composition comprising a nucleic acid comprising a nucleotide sequence encoding an EphA2 or EphA4 targeting moiety and an agent that inhibits or reduces LMW-PTP expression and / or activity. In yet another embodiment, the method of the invention comprises administering to a subject a composition comprising an EphA2 or EphA4 targeting moiety and a nucleic acid comprising a nucleotide sequence encoding an agent that inhibits or reduces LMW-PTP expression and / or activity, where the nucleic acid is operatively associated with the delivery vehicle. Pharmaceutical compositions are also provided by the present invention.
Owner:MEDIMMUNE LLC

Magnetic mesoporous silica core-shell structure affinity microsphere based on metal ion modification as well as preparation method and application thereof

The invention relates to the technical field of a functional material, and discloses a preparation method of a magnetic mesoporous silica core-shell structure affinity microsphere based on metal ion modification. The method comprises the following steps of: 1) preparing magnetic particles from hexahydrate ferric trichloride; 2) preparing particle dispersion liquid by utilizing the magnetic particles; 3) adding ethanol solution containing ethyl silicate and titanium tetrabutoxide to the particle dispersion liquid, carrying out ultrasound, agitation and magnetic separation, and removing template molecules to obtain the magnetic mesoporous silica core-shell structure taking the magnetic particles as a core and the SiO2 as a shell. Polypeptide and protein with low molecular weight can be gathered and purified from a complicated biological sample by utilizing the magnetic mesoporous silica core-shell structure affinity microsphere based on the metal ion modification. The purification and separation processes of complicated low-abundance protein and low-molecular weight protein sample are greatly simplified by utilizing the magnetic property of an affinity material; and the operation time is also shortened.
Owner:SHENZHEN UNIV +1

A magnetic mesoporous silica core-shell structure affinity microsphere based on metal ion modification and its preparation method and application

The invention relates to the technical field of a functional material, and discloses a preparation method of a magnetic mesoporous silica core-shell structure affinity microsphere based on metal ion modification. The method comprises the following steps of: 1) preparing magnetic particles from hexahydrate ferric trichloride; 2) preparing particle dispersion liquid by utilizing the magnetic particles; 3) adding ethanol solution containing ethyl silicate and titanium tetrabutoxide to the particle dispersion liquid, carrying out ultrasound, agitation and magnetic separation, and removing template molecules to obtain the magnetic mesoporous silica core-shell structure taking the magnetic particles as a core and the SiO2 as a shell. Polypeptide and protein with low molecular weight can be gathered and purified from a complicated biological sample by utilizing the magnetic mesoporous silica core-shell structure affinity microsphere based on the metal ion modification. The purification and separation processes of complicated low-abundance protein and low-molecular weight protein sample are greatly simplified by utilizing the magnetic property of an affinity material; and the operation time is also shortened.
Owner:SHENZHEN UNIV +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products